News about Industrial talks

Biocon Clarifies Media Reports on Possible Biocon Biologics Merger

Biocon has issued a clarification regarding recent media reports suggesting that the company is considering a potential merger of its unlisted subsidiary, Biocon Biologics Ltd. (BBL), along with IPO and share swap options.

Industrial talks | 14/11/2025 | By Dineshwori |  387

US FDA Appoints Richard Pazdur as Director of CDER

Pazdur is a 26-year veteran of the FDA and the Founding Director of its Oncology Center of Excellence (CoE). A regulatory innovator, he developed an integrated approach for cross-centre coordination of oncology product review to expedite the development of novel cancer therapies.

Industrial talks | 13/11/2025 | By Dineshwori |  332

Biocon Posts Robust Q2FY26 Results as Biosimilars and Generics Drive Double-Digit Growth

Biocon reported a robust financial performance for the second quarter of FY26, with total revenue rising 21 percent year-on-year (YoY) to INR 4,389 crore, compared to INR 3,623 crore in Q2 FY25.

Industrial talks | 12/11/2025 | By Dineshwori |  450

Novo Nordisk Confirms No Further Proposal Increase for Metsera Acquisition

Novo Nordisk has confirmed that it will not increase its offer to acquire Metsera, ending speculation of a potential bidding escalation.

Industrial talks | 10/11/2025 | By Dineshwori |  240

Senores Pharma Subsidiary Acquires Stake in Zoraya Pharmaceuticals

The acquisition of stakes in Zoraya Pharmaceuticals marks Senores Pharma’s strategic expansion in the US market through its wholly owned subsidiary.

Industrial talks | 06/11/2025 | By Dineshwori |  534

PBS Biotech Appoints Martin Simonetti as CEO

Simonetti is a veteran biotech executive who brings more than 40 years' industry expertise and leadership to PBS Biotech, including C-suite leadership, public and private financing and executing large-scale pharmaceutical collaborations.

Industrial talks | 04/11/2025 | By Dineshwori |  328

Helex Raises USD 3.5 Million in Seed Round to Advance Non-Viral Gene Therapies for Kidney Diseases

The new funding will support the development of Helex’s lead programme for ADPKD toward IND enabling studies, pipeline expansion leveraging its programmable LNP delivery and AI-based drug design platforms. The company is steadfast in building a robust franchise of renal programmes that profoundly improve and impact the lives of patients.

Industrial talks | 01/11/2025 | By Dineshwori |  307

Cipla Elevates Achin Gupta as Next Managing Director and Global CEO

Cipla has announced the elevation of Achin Gupta as its next Managing Director and Global Chief Executive Officer, effective April 1, 2026. Currently serving as the company’s Global Chief Operating Officer, Gupta will take over from Umang Vohra, who will step down upon completion of his term on March 31, 2026.

Industrial talks | 30/10/2025 | By Dineshwori |  422

Sanofi India Names Deepak Arora as MD Starting October 27, 2025

Approved by Sanofi India’s Board, the appointment places Deepak Arora in charge of steering the company’s strategic priorities and operations in line with its global vision.

Industrial talks | 28/10/2025 | By Dineshwori |  272

Eli Lilly Acquires Adverum to Embolden Gene-Therapy Eye-Care Ambitions

Eli Lilly has announced that it will acquire gene therapy developer Adverum Biotechnologies in a deal valued at up to USD 261.7 million, signalling a push into the ophthalmology space.

Industrial talks | 27/10/2025 | By Darshana |  206